Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils

Yun Zhou1, Kejing Song, Richard G Painter

  • 1Department of Microbiology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Insights

Cystic fibrosis transmembrane conductance regulator (CFTR) is crucial for human polymorphonuclear leukocytes (PMN) microbicidal activity. This study shows CFTR targets phagosomes and its defective recruitment in cystic fibrosis can be pharmacologically corrected.

Area of Science:

  • Immunology
  • Cell Biology
  • Medical Science

Background:

  • Optimal microbicidal activity in human polymorphonuclear leukocytes (PMN) depends on toxic agents like hypochlorous acid (HOCl) generated within phagosomes.
  • HOCl formation requires hydrogen peroxide (H2O2), NADPH oxidase, myeloperoxidase, and chloride ions, with chloride transport facilitated by chloride channels such as cystic fibrosis transmembrane conductance regulator (CFTR).
  • The precise phagosomal targeting of CFTR in PMN has remained undefined.

Purpose of the Study:

  • To investigate the phagosomal targeting of CFTR in human peripheral blood PMN.
  • To establish a model cell system for evaluating CFTR phagosomal recruitment.
  • To assess the potential for pharmacologic correction of impaired CFTR recruitment.

Main Methods:

  • Immunostaining and flow cytometry were used to analyze CFTR localization in mature phagosomes of human PMN.
  • A stable cell line expressing enhanced green fluorescent protein (EGFP)-tagged wild-type (wt) and mutant (DF508) CFTR was developed in PLB-985 cells.
  • Phagosomal association and colocalization with lysosomal-associated membrane protein 1 (LAMP-1) were examined in differentiated neutrophil-like cells.

Main Results:

  • Over 95% of mature phagosomes in human PMN were found to be CFTR positive.
  • EGFP-wt-CFTR fusion proteins successfully targeted phagosomes and colocalized with LAMP-1 in the model system.
  • Significantly reduced phagosomal localization of EGFP-DF508-CFTR indicated defective targeting, which was partially restored by the CFTR corrector VRT-325.

Conclusions:

  • CFTR is demonstrably recruited to phagosomes in PMN, a process essential for microbicidal function.
  • The DF508 mutation impairs CFTR phagosomal targeting, potentially contributing to reduced microbicidal capacity in cystic fibrosis.
  • Pharmacologic agents like VRT-325 show promise in correcting defective CFTR recruitment, offering a potential therapeutic strategy to enhance PMN microbicidal function in cystic fibrosis patients.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...